Diclofenac SR fast or fed state study design [Design Issues]

posted by xtianbadillo – Mexico, 2018-03-09 20:31 (2287 d 11:10 ago) – Posting: # 18518
Views: 5,961

❝ Hello, I need your advice please for diclofenac SR 75 mg:

❝ should study be conducted in fasting or fed state?


https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm188529.pdf

Active ingredient: Diclofenac Sodium
Form/Route: Extended Release Tablets/Oral
Recommended studies: 2 studies

1. Type of study: Fasting
Design: Single-dose, two-way, crossover in-vivo
Strength: 100 mg
Subjects: Healthy males and nonpregnant females, general population.
Additional Comments:
______________________________________________________________________________
2. Type of study: Fed
Design: Single-dose, two-way, crossover in-vivo
Strength: 100 mg
Subjects: Healthy males and nonpregnant females, general population.
Additional comments:
_______________________________

Complete thread:

UA Flag
Activity
 Admin contact
23,056 posts in 4,840 threads, 1,641 registered users;
87 visitors (0 registered, 87 guests [including 9 identified bots]).
Forum time: 08:41 CEST (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5